Meta‐analysis of randomized controlled trials of external‐beam radiation versus transarterial chemoembolization for hepatocellular carcinoma
Cancer · 2025-02 · 131 (3)
DOI: 10.1002/cncr.35720 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cancer, online erschienen am 30.01.2025. Verfasst von Ryan A Kuehnle und 12 weiteren Autor:innen. Beteiligte Einrichtung: Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
External‐beam radiation (EBRT) is a noninvasive therapeutic alternative to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). The objective of this study was to conduct a systematic review and meta‐analysis of prospective randomized clinical trials to assess the clinical efficacy of EBRT versus TACE for HCC as either a definitive monotherapy or as a bridge to transplantation/surgery.
Methods
A systematic review and meta‐analysis were performed to include prospective randomized trials comparing EBRT versus TACE. Data was analyzed with random and fixed‐effects models. The inconsistency index (I 2 ) was chosen to assess heterogeneity. Three publications were included with a total of 142 patients. Outcomes included local control (LC), overall survival (OS), progression‐free survival (PFS), and occurrences of grade ≥3 toxicity. Comparisons are reported as hazard ratios (HRs) or risk ratios (RRs) with 95% confidence intervals (CIs).
Results
There were three randomized trials that met inclusion criteria. The EBRT was delivered in three to 15 fractions with a total dose between 30 and 75 gray(Gy). EBRT was associated with significantly improved LC (HR, 0.16; 95% CI, 0.08–0.34; I 2 = 0%) and PFS (HR, 0.37; 95% CI, 0.23–0.60; I 2 , 0%) compared with TACE. There was no significant difference between EBRT and TACE in OS (RR, 0.79; 95% CI, 0.51–1.22; I 2 = 0%) or grade ≥3 toxicity (RR, 0.86; 95% CI, 0.31–2.37; I 2 = 57%). None of the analyses had statistically significant heterogeneity.
Conclusions
Compared with TACE, EBRT yields superior LC and PFS without providing a survival benefit in early and intermediate stage HCC. Additional larger prospective randomized controlled trials should be conducted to further investigate differences in clinical outcomes amongst patients with more advanced disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Northwell, New Hyde Park, New York, USA.
- Division of Radiation Oncology, Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Radiation Oncology Branch, Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
- Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Department of Radiation Oncology, Southwestern Medical Center, University of Texas, Dallas, Texas, USA.
ORCID-Profile: Ryan A Kuehnle, Ethan B Ludmir, Nina Sanford, Colin M Court, Krishan R Jethwa
Zitieren
APA
Kuehnle, R. A., Tchelebi, L. T., Ludmir, E. B., Escorcia, F. E., Shrestha, S., Sanford, N., Court, C. M., Ryckman, J. M., Arora, S. P., Lehrer, E. J., Gelfond, J., Jethwa, K. R., & Newman, N. B. (2025). Meta‐analysis of randomized controlled trials of external‐beam radiation versus transarterial chemoembolization for hepatocellular carcinoma. Cancer, 131(3). https://doi.org/10.1002/cncr.35720
Vancouver
Kuehnle RA, Tchelebi LT, Ludmir EB, Escorcia FE, Shrestha S, Sanford N, et al. Meta‐analysis of randomized controlled trials of external‐beam radiation versus transarterial chemoembolization for hepatocellular carcinoma. Cancer. 2025;131(3). doi:10.1002/cncr.35720
BibTeX
@article{Kuehnle2025,
author = {Kuehnle, Ryan A and Tchelebi, Leila T and Ludmir, Ethan B and Escorcia, Freddy E and Shrestha, Sabi and Sanford, Nina and Court, Colin M and Ryckman, Jeff M and Arora, Sukeshi P and Lehrer, Eric J and Gelfond, Jonathan and Jethwa, Krishan R and Newman, Neil B},
title = {Meta‐analysis of randomized controlled trials of external‐beam radiation versus transarterial chemoembolization for hepatocellular carcinoma},
journal = {Cancer},
year = {2025},
volume = {131},
number = {3},
doi = {10.1002/cncr.35720}
}
EUVIMED